5 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... DVT = deep vein ... thrombosis; PE = pulmonary ... #DOAC #VTE #Malignancy ... Anticoagulation #Management #Hematology
Recurrent / Breakthrough DVT During Anticoagulation

Subtherapeutic Anticoagulation
Hypercoagulable State 
 - Antithrombin deficiency 
 - Hypercoagulability ot
/ Breakthrough DVT ... Breakthrough #Recurrent #DVT ... #VTE #anticoagulation ... #hematology #differential ... #algorithm
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
and incidental DVT ... without concomitant DVT ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... Anticoagulation #Management #Hematology
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
and Management Algorithm ... Breakthrough #Thrombosis #Algorithm ... #Extension #VTE ... #DVT #Hematology ... Management #Diagnosis #Differential
Approach to Thrombotic Microangiopathy (TMA) - Differential Diagnosis and Management Algorithm

Suspected TMA: Unexplained thrombocytopenia + MAHA
Microangiopathy (TMA) - Differential ... and Management Algorithm ... TMA: Unexplained thrombocytopenia ... aPTT normal • DAT ... #hematology